Patients in Western Australia now have access to a cutting-edge prostate cancer treatment, low-dose rate (LDR) brachytherapy, with data from their treatment contributing to a national research effort.
The LIBERATE clinical registry, previously established at Icon Cancer Centre in Victoria, has now expanded to WA, helping to advance understanding of the treatment’s benefits and improve future care for men with prostate cancer.
Radiation oncologist, Dr Eve Tiong, who leads the study in WA at Icon Cancer Centre, welcomes this expansion, noting the many benefits for patient care.
“LDR brachytherapy delivers highly targeted radiation directly to prostate cancer cells, minimising damage to surrounding healthy tissue,” says Dr Tiong. “It’s a quick outpatient procedure lasting approximately 30minutes.”
